This is a competing renewal of a grant in which we added on cognitive testing to two randomized clinical trials of chronic disease prevention in women: the Women's Health Study (WHS) tests low-dose aspirin and antioxidant supplementation in healthy women and the Women's Antioxidant Cardiovascular Study (WACS) tests antioxidant and folate supplementation in women with existing cardiovascular disease. These agents are also hypothesized to prevent Alzheimer disease (AD); since preventive efforts are often best focused at the earliest stages of disease development, our aim in the original application was to investigate whether these treatments might protect against early cognitive decline, a pre-clinical marker of AD risk, in community dwelling women. We conducted telephone cognitive assessments at 3 points in time over 5 years in 6,387 WHS subjects and 2,836 WACS subjects, aged 65 years and older. Both trials received NIH funding to extend follow-up by 3 years to determine whether an average 10 years on the study agents prevent cardiovascular disease or cancer; compliance and follow-up in the trials remain high after 8 years. Since cognitive decline develops slowly over a long period of time, it is likely that long durations of treatment are also necessary to prevent or delay decline. Thus, the extended follow-up of WHS and WACS provides a truly unique opportunity to extend the cognitive sub-studies too, making these among the largest and longest-term clinical trials of neuroprotection; we propose to conduct a single extra wave of cognitive testing during the final year of each trial. Using blood samples obtained from over 70 percent of participants in both trials, we will also examine interactions between these treatments and apolipoprotein E genotype. Importantly, the cognitive sub-studies have been highly successful to date, and establish: (1) effective randomization of subjects, (2) high participation and follow-up in cognitive testing and (3) that our telephone instrument is reliable, valid, and can detect expected relations with cognitive decline. In this revision, we propose to enhance our instrument by adding a 2nd test of executive function (a strong predictor of AD risk) and a test of hearing impairment. WHS has been extended until August 2004 and WACS until February 2006, thus there is a limited window of opportunity for taking advantage of the long-term follow-up.
| Samieri, Cécilia; Morris, Martha-Clare; Bennett, David A et al. (2018) Fish Intake, Genetic Predisposition to Alzheimer Disease, and Decline in Global Cognition and Memory in 5 Cohorts of Older Persons. Am J Epidemiol 187:933-940 |
| Vercambre, Marie-Noel; Berr, Claudine; Ritchie, Karen et al. (2013) Caffeine and cognitive decline in elderly women at high vascular risk. J Alzheimers Dis 35:413-21 |
| Kim, Dae Hyun; Grodstein, Francine; Rosner, Bernard et al. (2013) Seafood types and age-related cognitive decline in the Women's Health Study. J Gerontol A Biol Sci Med Sci 68:1255-62 |
| Samieri, Cécilia; Grodstein, Francine; Rosner, Bernard A et al. (2013) Mediterranean diet and cognitive function in older age. Epidemiology 24:490-9 |
| Grodstein, Francine; O'Brien, Jacqueline; Kang, Jae Hee et al. (2013) Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med 159:806-14 |
| Vercambre, Marie-Noël; Grodstein, Francine; Berr, Claudine et al. (2012) Mediterranean diet and cognitive decline in women with cardiovascular disease or risk factors. J Acad Nutr Diet 112:816-23 |
| Okereke, Olivia I; Rosner, Bernard A; Kim, Dae H et al. (2012) Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol 72:124-34 |
| Rist, Pamela M; Kang, Jae H; Buring, Julie E et al. (2012) Migraine and cognitive decline among women: prospective cohort study. BMJ 345:e5027 |
| Vercambre, Marie-Noel; Grodstein, Francine; Manson, JoAnn E et al. (2011) Physical activity and cognition in women with vascular conditions. Arch Intern Med 171:1244-50 |
| Okereke, Olivia I; Kurth, Tobias; Pollak, Michael N et al. (2010) Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians' Health Study II. Neuroepidemiology 34:200-7 |
Showing the most recent 10 out of 23 publications
